ACHC
Acadia Healthcare Company, Inc.14.43
+0.21+1.48%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Q&A details ramp fixes, no closures
Q&A reinforced prepared remarks on operational discipline and strong demand but added color on new-facility ramp hurdles—licensure and billing delays, not demand—and vows to fix via standardized processes for 2026 openings. CEO Osteen confirmed the value creation review rolls on, eyeing service lines and leadership layers for rightsizing, while signaling fewer bed closures ahead as the prior accelerated pace ends. The $200 million EBITDA unlock from recent beds sits inside five years. Management dismissed managed Medicaid length-of-stay worries as business-as-usual and touted referral ties via outcomes data. Confident tone; watch facility ramps.
Key Stats
Market Cap
1.33BP/E (TTM)
12.44Basic EPS (TTM)
1.16Dividend Yield
0%Recent Filings
10-K
FY2025 results
Acadia drove FY2025 revenue to $3.3B, up 5.0% y/y, with same-facility growth of 4.9% from 2.1% patient day gains and 2.8% revenue per day. Yet $996M goodwill impairment—triggered by litigation costs, Medicaid referral cuts, and stock plunge—swamped operations, yielding a $1.1B net loss. Q4 momentum faltered amid $52.7M liability reserve hikes and $571M capex for beds/JVs. Debt hit $2.5B after refinancing, but $595M revolver room holds. Labor shortages crimp margins. Ongoing probes risk quarterly cash drains.
8-K
Q4 revenue up, EBITDA down sharply
Acadia reported Q4 revenue of $821.5M, up 6.1% YoY on 3.1% patient day growth, but Adjusted EBITDA fell to $99.8M from $153.1M after $52.7M PLGL reserve hike and $996.2M goodwill impairment. Full-year revenue hit $3.31B; new CEO Debbie Osteen targets operational fixes. Guidance eyes $3.37-3.45B revenue, $575-610M Adjusted EBITDA. Headwinds loom from Medicaid shifts.
8-K
CEO Hunter exits Acadia
Acadia Healthcare's CEO Christopher H. Hunter departed effective January 20, 2026, also resigning from the board. The separation agreement grants him 1.5x base plus target bonus over 18 months, a $1,785,000 retention payout, prorated PSUs, and health benefits—conditioned on a full release and covenants. Leadership transition leaves interim arrangements undisclosed.
8-K
Osteen replaces Hunter as CEO
Acadia Healthcare ousted CEO Chris Hunter on January 20, 2026, installing former CEO Debra K. Osteen back in the role plus Board seat. She gets $1.061M base, 125% target bonus, and options for 1,125,000 shares at $11.68 strike tied to VWAP hurdles from $25. Leadership swap amid macro headwinds. Board seeks long-term successor.
8-K
Reaffirms 2025 guidance
Acadia Healthcare reaffirmed its 2025 guidance ahead of its January 13, 2026, J.P. Morgan Healthcare Conference presentation. Revenue targets $3.28-$3.30 billion; Adjusted EBITDA $601-$611 million; adjusted EPS $1.94-$2.04. Guidance holds firm. Risks include Medicaid cuts from OBBBA and integration hurdles.
IPO
Employees
Sector
Industry
ADUS
Addus HomeCare Corporation
113.49-1.65
ARDT
Ardent Health, Inc.
8.93+0.03
CYH
Community Health Systems, Inc.
3.25+0.03
EHC
Encompass Health Corporation
108.01+0.42
FCHS
First Choice Healthcare Solutio
0.01+0.00
HCA
HCA Healthcare, Inc.
469.79-7.19
NHC
National HealthCare Corporation
138.93-0.94
NUTX
Nutex Health Inc.
171.72-4.06
RHEP
Regional Health Properties, Inc
1.37-0.03
UHS
Universal Health Services, Inc.
222.64-1.23